Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors

NCT05450562 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
33
Enrollment
INDUSTRY
Sponsor class

Stopped Early discontinuation based on strategic sponsor decision not driven by any safety concerns

Conditions

Interventions

Sponsor

Sanofi